Gut micoriobiome & metabolites for prediction of Subclinical Atherosclerosis in Older Patients with Non-Alcoholic Fatty Liver Disease
To study the incidence of subacute atherosclerosis in the normal body mass index, overweight or obese, metabolic syndrome, dietary consumption, genetic diversity, and severity of liver disease in elderly individuals with and without non-alcoholic fatty liver disease.
To investigate the relationship between gut microbiota profile and the level of metabolites (including TMAO) in blood, and their association with the occurrence of calcified plaques in the coronary arteries among elderly individuals with and without non-alcoholic fatty liver disease
We use cookies
We use cookies to improve your experience and performance on our website. You can manage your preferences.
NecessaryAlways Active
Necessary cookies are required to help a website usable by enabling core functions and access to secure areas of the website. The website cannot be function properly without these cookies and they are enabled by default and cannot be disabled.
Analytics cookies help website to understand how visitors interact through the website. These cookies help to improve user experiences by collecting and reporting information.
Marketing cookies are used to track visitors across websites to display relevant advertisements for the individual user and thereby more valuable for publishers and third party advertisers.